MedTrace Logo

Study of CD38 and CD56 in Chronic Myeloid Leukemia

NCT07740603 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-08-05

No results posted yet for this study

Summary

Chronic myeloid leukemia is a myelo-proliferative neoplasm characterized by abnormal proliferation of myeloid cells. There is an accumulation of mature granulocytes in the blood and bone marrow.

The aim of the study is to study expression of CD38 and CD56 in patients with Chronic myeloid leukemia.

Conditions

  • Chronic Myeloid Leukemia (CML)

Interventions

DIAGNOSTIC_TEST

cd 38 and cd 56

prescence of high percentage of cd38 and cd 56

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-06-01
Completion
2027-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07740603 on ClinicalTrials.gov